Court of Justice ruling in Paroxetine

Published date19 February 2020
Subject MatterReverse Payment Settlement Agreements,Patents,Appeals,EU,Prescription Drugs,TFEU,Generic Drugs,Abuse of Dominance,Anti-Competitive,Patent Litigation,Pharmaceutical Patents,UK Competition and Markets Authority (CMA),UK Brexit,European Court of Justice (ECJ),UK Competition Appeal Tribunal (CAT)
AuthorJames R.M. Killick,Jérémie Jourdan,Aqeel Kadri,Marc Israel,Kate Kelliher
Law FirmWhite & Case LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT